MIRA
Price:
$1.31
Market Cap:
$22.16M
MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. The company focuses on the development and commercialization of a new molecular synthetic tetrahydrocannabinol (THC) analog under investigation for the treatment of adult patients with anxiety and cognitive decline typically associated with early-stage dementia. It is developing MIRA1a, a synthetic cannabinoid analog to treat anxiety and chronic pain by targeting the cannabinoid type 1 and type 2 receptors. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is headquartered in Baltimore, Maryland.
Industry
Drug Manufacturers - General
IPO Date
2023-08-14
Stock Exchange
NASDAQ
Ticker
MIRA
According to MIRA Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -2.79. This represents a change of 40.26% compared to the average of -1.99 of the last 4 quarters.
The mean historical PE Ratio of MIRA Pharmaceuticals, Inc. over the last ten years is -290.61. The current -2.79 PE Ratio has changed -3.99% with respect to the historical average. Over the past ten years (40 quarters), MIRA's PE Ratio was at its highest in in the December 2022 quarter at -0.04. The PE Ratio was at its lowest in in the March 2021 quarter at -415.38.
Average
-290.61
Median
-13.41
Minimum
-1392.26
Maximum
-1.63
Discovering the peaks and valleys of MIRA Pharmaceuticals, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 37.81%
Maximum Annual PE Ratio = -1.63
Minimum Annual Increase = -96.88%
Minimum Annual PE Ratio = -1392.26
Year | PE Ratio | Change |
---|---|---|
2024 | -2.24 | 37.81% |
2023 | -1.63 | -87.87% |
2022 | -13.41 | -69.16% |
2021 | -43.49 | -96.88% |
The current PE Ratio of MIRA Pharmaceuticals, Inc. (MIRA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-5.76
5-year avg
-290.61
10-year avg
-290.61
MIRA Pharmaceuticals, Inc.’s PE Ratio is
Company | PE Ratio | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like MIRA Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like MIRA Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is MIRA Pharmaceuticals, Inc.'s PE Ratio?
How is the PE Ratio calculated for MIRA Pharmaceuticals, Inc. (MIRA)?
What is the highest PE Ratio for MIRA Pharmaceuticals, Inc. (MIRA)?
What is the 3-year average PE Ratio for MIRA Pharmaceuticals, Inc. (MIRA)?
What is the 5-year average PE Ratio for MIRA Pharmaceuticals, Inc. (MIRA)?
How does the current PE Ratio for MIRA Pharmaceuticals, Inc. (MIRA) compare to its historical average?